USPTO serial 79324881
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Institut National de la Santé et de la Recherche Médicale (INSERM)
FR
Other trademarks owned by Institut National de la Santé et de la Recherche Médicale (INSERM)
Institut National de la Santé et de la Recherche Médicale (INSERM)
FR
Other trademarks owned by Institut National de la Santé et de la Recherche Médicale (INSERM)
Institut National de la Santé et de la Recherche Médicale (INSERM)
FR
Other trademarks owned by Institut National de la Santé et de la Recherche Médicale (INSERM)
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cathleen E. Stadecker
Cathleen E. Stadecker Downs Rachlin Martin PLLC199 Main Street, PO Box 190Burlington, VT 05402-0190UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations; diagnostic reagents; all the aforesaid goods reserved for the study of cellular metabolic responses, particularly in the context of research related to anti-cancer therapies | ACTIVE | — |
| 009 | Scientific research apparatus and instruments, namely, diagnostic apparatus for profiling the global metabolic capacities and dependencies of cells for laboratory or research use; recorded software programs for analyzing scientific and medical research results; laboratory instruments, namely, medical laboratory research instruments for profiling the global metabolic capacities and dependencies of cells; all the aforesaid goods reserved for the study of cellular metabolic responses, particularly in the context of research related to anti-cancer therapies | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing in the field of cellular metabolic responses, medical diagnostic tools, anti-cancer therapies; scientific laboratory services; software development and design; research and development of new products for third parties; medical research; all the aforesaid services reserved for the study of cellular metabolic responses, particularly in the context of research related to anti-cancer therapies | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 20, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 3, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 17, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 17, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Aug 16, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 16, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 16, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 1, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 5, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 5, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 27, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 15, 2022 | CRSN | CORRECTION SENT TO IB | — |
| Aug 10, 2022 | CRCR | CORRECTION CREATED FOR IB | — |
| Aug 2, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 2, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 2, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 1, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 30, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 25, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 7, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 7, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 31, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 30, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |